Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of trastuzumab in haemodialysis.
Gori S, Foglietta J, Lunardi G, Inno A, Cardinali B, Millo E, Del Mastro L, Nunzi EG, Crinò L. Gori S, et al. Among authors: cardinali b. Breast J. 2015 May-Jun;21(3):329-31. doi: 10.1111/tbj.12407. Epub 2015 Mar 19. Breast J. 2015. PMID: 25790224 No abstract available.
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP. Boero S, et al. Among authors: cardinali b. J Transl Med. 2015 Oct 8;13:324. doi: 10.1186/s12967-015-0680-0. J Transl Med. 2015. PMID: 26450443 Free PMC article.
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP. Boero S, et al. Among authors: cardinali b. J Transl Med. 2016 Jan 22;14:24. doi: 10.1186/s12967-016-0779-y. J Transl Med. 2016. PMID: 26801979 Free PMC article. No abstract available.
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial.
Conte B, Bruzzone M, Lambertini M, Poggio F, Bighin C, Blondeaux E, De Laurentiis M, Valle E, Cognetti F, Nisticò C, De Placido S, Garrone O, Gamucci T, Montemurro F, Puglisi F, Cardinali B, Fregatti P, Miglietta L, Boccardo F, Ceppi M, Del Mastro L; GIM2 Investigators. Conte B, et al. Among authors: cardinali b. Eur J Cancer. 2020 Sep;136:43-51. doi: 10.1016/j.ejca.2020.05.007. Epub 2020 Jul 4. Eur J Cancer. 2020. PMID: 32634760 Clinical Trial.
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study.
Blondeaux E, Ferreira AR, Poggio F, Puglisi F, Bighin C, Sottotetti F, Montemurro F, Poletto E, Lai A, Sini V, Minuti G, Mura S, Fontana A, Fregatti P, Cardinali B, Lambertini M, Del Mastro L. Blondeaux E, et al. Among authors: cardinali b. ESMO Open. 2020 Aug;5(4):e000719. doi: 10.1136/esmoopen-2020-000719. ESMO Open. 2020. PMID: 32817059 Free PMC article.
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis.
Cardinali B, Tasso R, Piccioli P, Ciferri MC, Quarto R, Del Mastro L. Cardinali B, et al. Cancers (Basel). 2022 May 7;14(9):2317. doi: 10.3390/cancers14092317. Cancers (Basel). 2022. PMID: 35565446 Free PMC article. Review.
68 results